medical care, HIV can gradually weaken the immune system and develop into Acquired Immunodeficiency Syndrome (AIDS), the most advanced stage of infection.

HIV can spread through certain body fluids, including blood, semen, vaginal fluids, rectal fluids, and breast milk. Transmission can occur through unprotected sexual contact, sharing contaminated needles, unsafe blood exposure, and transmission from a mother to her child during pregnancy, childbirth, or breastfeeding.

However, HIV does not spread through ordinary daily contact, such as:

• Hugging or shaking hands.

• Sharing food or drinking water.

• Using the same toilet.

• Sitting beside someone with HIV.

• Mosquito or insect bites.

Modern HIV prevention combines medical knowledge with practical protective measures. Its main purpose is to reduce new infections while helping individuals understand their health and make informed decisions.

Why Were HIV Prevention Methods Developed?

HIV prevention became an important global public health priority after the first recognised AIDS cases in the early 1980s. As researchers learned more about transmission, governments and healthcare organisations introduced awareness programmes, testing facilities, safer medical practices, and antiretroviral medicines.

Today, HIV prevention includes several approaches, such as condoms, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), regular testing, and treatment for people living with HIV.

Importance of HIV Prevention in Modern Healthcare

Why HIV Prevention Matters Today

HIV prevention remains important because new infections continue to affect communities worldwide. Although medical progress has improved HIV diagnosis and long-term health management, awareness gaps, stigma, and unequal access to healthcare remain significant challenges.

Prevention helps individuals understand potential exposure risks and take appropriate precautions before infection occurs.

The main benefits include:

• Reducing the number of new HIV infections.

• Supporting early diagnosis through appropriate testing.

• Protecting sexual and reproductive health.

• Reducing mother-to-child transmission.

• Improving public awareness of HIV.

• Encouraging responsible medical and healthcare practices.

• Supporting people living with HIV without discrimination.

Who Can Benefit from HIV Prevention?

HIV prevention is relevant to everyone because anyone can potentially encounter an exposure risk.

Certain groups may benefit from additional prevention measures, including people with partners whose HIV status is unknown, individuals with multiple sexual partners, people who share injection equipment, and healthcare workers who may experience occupational exposure.

Pregnant women also require appropriate HIV screening because early diagnosis and medical management can significantly reduce the possibility of transmission to a baby.

Understanding Different HIV Prevention Methods

The following table explains commonly used prevention approaches.

PrEP and PEP: Understanding the Difference

Pre-exposure prophylaxis, commonly known as PrEP, involves using prescribed antiretroviral medicine before potential HIV exposure. It is intended for HIV-negative individuals who may have an increased risk of infection.

Post-exposure prophylaxis, known as PEP, is an emergency medical approach used after a possible HIV exposure.

PEP should begin as soon as possible and within 72 hours of exposure. The prescribed course generally lasts 28 days.

These approaches are different and should only be used after appropriate medical assessment.

Recent Updates in HIV Prevention and Medical Research

Medical Developments During 2025–2026

HIV prevention research has continued to develop, particularly in long-acting preventive medicines, diagnostic technologies, and community-based testing.

One important development occurred on 14 July 2025, when the World Health Organization (WHO) recommended injectable lenacapavir as an additional pre-exposure prophylaxis option.

Lenacapavir is a long-acting antiretroviral medicine administered twice yearly for HIV prevention. It provides another option for people who find daily preventive tablets difficult to maintain. WHO also recommended using rapid diagnostic tests to support the initiation and continuation of long-acting injectable PrEP.

1. Long-Acting HIV Prevention Medicines

Medical research is exploring preventive medicines that remain active for longer periods. Lenacapavir represents an important development because its twice-yearly schedule may help address challenges associated with taking daily tablets.

2. Improved HIV Testing Approaches

Rapid diagnostic testing is becoming increasingly important. These tests can support earlier identification of HIV and help healthcare professionals make appropriate medical decisions.

3. Greater Focus on Combination Prevention

Modern prevention programmes increasingly combine different approaches, including condoms, PrEP, testing, counselling, and treatment. Using appropriate methods together can provide broader protection.

4. Better Integration of HIV and General Healthcare

WHO's 2025 recommendations also highlighted integrating HIV care with mental health support and the management of conditions such as diabetes and hypertension. This reflects a broader approach to long-term health.

According to the UNAIDS Global AIDS Update 2025, approximately 1.3 million people acquired HIV worldwide during 2024. The report also highlighted continuing gaps in prevention and the importance of expanding access to newer medical approaches.

These developments represent progress, but availability and approval can differ between countries. Patients should check current national recommendations before considering a new preventive medicine.

Laws and Policies Related to HIV Prevention in India

India's HIV Prevention Framework

India has developed national programmes to improve HIV awareness, prevention, diagnosis, and medical care.

The National AIDS Control Organisation (NACO), operating under the Ministry of Health and Family Welfare, coordinates the country's national HIV response.

The National AIDS Control Programme (NACP) focuses on reducing new HIV infections, improving diagnosis, supporting affected communities, and strengthening prevention activities.

Important areas include:

• HIV awareness and public education.

• Counselling and testing programmes.

• Prevention of mother-to-child transmission.

• Condom awareness and distribution.

• Prevention of sexually transmitted infections.

• Antiretroviral treatment and continued medical monitoring.

• Community participation and stigma reduction.

HIV and AIDS (Prevention and Control) Act, 2017

India introduced the HIV and AIDS (Prevention and Control) Act, 2017, which came into force on 10 September 2018.

The legislation establishes important protections for people living with HIV and those affected by the condition.

Its major provisions include:

Protection Against Discrimination: The Act prohibits discrimination against individuals based on their HIV status in areas covered by the legislation.

Informed Consent: HIV testing and medical interventions generally require informed consent, subject to specific legal exceptions.

Confidentiality: HIV-related personal information must be protected. Unauthorised disclosure is restricted under the Act.

Equal Access to Healthcare: The legislation establishes protections relating to healthcare access and treatment for people affected by HIV.

Legal Protection: The Act provides mechanisms for addressing discrimination and violations of protected rights.

NACO's National HIV Counselling and Testing Guidelines, 2024, provide a framework for HIV screening, confirmatory testing, counselling, and appropriate follow-up.

Testing generally involves an initial screening process followed by additional testing according to the national diagnostic algorithm. A single reactive screening result should not automatically be treated as a confirmed diagnosis.

Pregnant women are also included in national efforts to identify HIV and syphilis early and support appropriate medical management.

Important: Medical guidelines can change as research develops. Individuals should follow the latest national recommendations and consult qualified healthcare professionals for personal medical decisions.

Tools and Resources for HIV Prevention and Health Protection

HIV Testing and Awareness Resources

Reliable educational materials and appropriate diagnostic resources help individuals understand HIV prevention and make informed health decisions.

Useful resource categories include:

• HIV Risk Assessment Tools: General educational questionnaires can help people understand possible exposure situations.

• Testing Information Guides: Educational materials explain different HIV tests, testing procedures, and diagnostic windows.

• PrEP and PEP Information: Medical guidance helps individuals understand preventive medicines and when they may be appropriate.

• Health Education Applications: Digital learning platforms can provide information about HIV transmission, prevention, and general sexual health.

• Medical Consultation Records: Personal health records help individuals keep track of test dates, prescribed medicines, and follow-up appointments.

• Awareness Templates: Educational posters, presentation formats, and information sheets can support community awareness programmes.

Important Medical Resources in India

NACO provides national HIV-related guidelines, educational documents, prevention information, and programme updates.

Integrated Counselling and Testing Centres (ICTCs) support HIV counselling and testing under the national programme.

Antiretroviral Therapy (ART) centres provide medical management for people diagnosed with HIV.

The national HIV/AIDS helpline, 1097, provides information and guidance in India.

The following simplified process explains how individuals can approach HIV prevention.

Frequently Asked Questions About HIV Prevention

1. What Is the Most Effective Way to Prevent HIV?

HIV prevention works best through a combination of appropriate protective measures. These may include using condoms, taking prescribed PrEP when appropriate, avoiding shared injection equipment, and undergoing HIV testing. The right approach depends on individual exposure risks and medical circumstances.

2. What Is PrEP, and Who Should Consider It?

PrEP is preventive antiretroviral medicine taken by people who do not have HIV but may face an increased risk of infection. It is available in different forms, including oral tablets and certain long-acting injections. A healthcare professional can assess eligibility and recommend an appropriate option.

3. How Soon Should Someone Start PEP After Possible HIV Exposure?

PEP should be started as soon as possible, preferably within 24 hours and no later than 72 hours after potential exposure. The usual prescribed course lasts 28 days. Immediate medical assessment is important because delaying treatment can reduce its effectiveness.

4. Can Someone With HIV Live a Healthy Life?

Yes. Modern antiretroviral therapy helps people living with HIV manage the condition and maintain their health over the long term. Consistent treatment and medical monitoring are important. People who maintain an undetectable viral load do not transmit HIV through sexual contact. This is commonly known as Undetectable = Untransmittable (U=U).

5. Can HIV Be Detected Through a Regular Blood Test?

HIV requires a specific diagnostic test. Different testing methods detect HIV antibodies, antigens, or viral material. The appropriate test depends on the time since possible exposure. A negative result during the testing window may require another test according to medical guidance.

Conclusion

HIV prevention is an important part of modern healthcare and public health awareness. Medical developments, including PrEP, PEP, rapid diagnostic testing, and long-acting preventive medicines, have expanded the available approaches to reducing HIV transmission.

Disclaimer: The information provided in this article is for informational purposes only. We do not make any claims or guarantees regarding the accuracy, reliability, or completeness of the information presented. The content is not intended as professional advice and should not be relied upon as such. Readers are encouraged to conduct their own research and consult with appropriate professionals before making any decisions based on the information provided in this article.